Debt-to-equity in % of Travere Therapeutics, Inc. from Q3 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Travere Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q3 2014 to Q3 2025.
  • Travere Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 1029%, a 19% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Travere Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 1029% +162% +19% 30 Sep 2025
Q2 2025 2238% +1841% +463% 30 Jun 2025
Q1 2025 2770% +2420% +691% 31 Mar 2025
Q4 2024 1863% +1560% +515% 31 Dec 2024
Q3 2024 866% +481% +125% 30 Sep 2024
Q2 2024 398% -158% -28% 30 Jun 2024
Q1 2024 350% -160% -31% 31 Mar 2024
Q4 2023 303% -189% -38% 31 Dec 2023
Q3 2023 386% +80% +26% 30 Sep 2023
Q2 2023 555% +331% +148% 30 Jun 2023
Q1 2023 510% +338% +197% 31 Mar 2023
Q4 2022 491% +357% +265% 31 Dec 2022
Q3 2022 305% +167% +121% 30 Sep 2022
Q2 2022 224% +92% +69% 30 Jun 2022
Q1 2022 172% +42% +33% 31 Mar 2022
Q4 2021 135% -7% -4.7% 31 Dec 2021
Q3 2021 138% 0% -0.33% 30 Sep 2021
Q2 2021 133% -11% -8% 30 Jun 2021
Q1 2021 130% -22% -14% 31 Mar 2021
Q4 2020 141% -5% -3.2% 31 Dec 2020
Q3 2020 139% +5% +3.6% 30 Sep 2020
Q2 2020 144% +16% +12% 30 Jun 2020
Q1 2020 151% +38% +34% 31 Mar 2020
Q4 2019 146% +49% +50% 31 Dec 2019
Q3 2019 134% +48% +56% 30 Sep 2019
Q2 2019 128% +57% +79% 30 Jun 2019
Q1 2019 113% +42% +58% 31 Mar 2019
Q4 2018 97% +25% +35% 31 Dec 2018
Q3 2018 86% +15% +21% 30 Sep 2018
Q2 2018 72% 0% +0.45% 30 Jun 2018
Q1 2018 72% +1% +1.3% 31 Mar 2018
Q4 2017 72% +4% +6.3% 31 Dec 2017
Q3 2017 71% +3% +3.8% 30 Sep 2017
Q2 2017 71% +3% +3.8% 30 Jun 2017
Q1 2017 71% -14% -16% 31 Mar 2017
Q4 2016 68% -37% -35% 31 Dec 2016
Q3 2016 68% -92% -57% 30 Sep 2016
Q2 2016 69% -244% -78% 30 Jun 2016
Q1 2016 84% -514% -86% 31 Mar 2016
Q4 2015 105% +854% 31 Dec 2015
Q3 2015 160% +908% 30 Sep 2015
Q2 2015 313% 30 Jun 2015
Q1 2015 598% 31 Mar 2015
Q4 2014 -749% 31 Dec 2014
Q3 2014 -748% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.